About CARTANA
CARTANA is a company based in Solna (Sweden) founded in 2017 by Xiaoyan Qian, Malte Kuhnemund, and Francesca Bignami was acquired by 10X Genomics in August 2020.. CARTANA has raised $329.93 thousand across 3 funding rounds from investors including 10X Genomics, European Union and Almi Invest. CARTANA operates in a competitive market with competitors including Nanopore, PacBio, Metabolon, Maze Therapeutics and Alector, among others.
- Headquarter Solna, Sweden
- Founders Xiaoyan Qian, Malte Kuhnemund, Francesca Bignami
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$329.93 K (USD)
in 3 rounds
-
Latest Funding Round
$424.5 K (USD), Grant
Jan 01, 2020
-
Investors
10X Genomics
& 2 more
-
Employee Count
Employee Count
-
Acquired by
10X Genomics
(Aug 01, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of CARTANA
CARTANA has successfully raised a total of $329.93K across 3 strategic funding rounds. The most recent funding activity was a Grant round of $424.5 thousand completed in January 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Grant — $424,497
-
First Round
First Round
(09 Oct 2018)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2020 | Amount | Grant - CARTANA | Valuation |
investors |
|
| Dec, 2019 | Amount | Grant - CARTANA | Valuation |
investors |
|
| Oct, 2018 | Amount | Seed - CARTANA | Valuation | Almi Invest |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in CARTANA
CARTANA has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include 10X Genomics, European Union and Almi Invest. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors are invested in by corporate-backed Almi Invest.
|
Founded Year | Domain | Location | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location | |
|
Instrument systems for genomic research and sequencing libraries are developed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by CARTANA
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - CARTANA
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cartana Comparisons
Competitors of CARTANA
CARTANA operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nanopore, PacBio, Metabolon, Maze Therapeutics and Alector, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Nanopore-based electronic systems for single-molecule analysis are developed.
|
|
| domain | founded_year | HQ Location |
Instrument systems and software for single-molecule real-time sequencing are developed.
|
|
| domain | founded_year | HQ Location |
Solutions for biomarker discovery and diagnostic testing are provided.
|
|
| domain | founded_year | HQ Location |
Genetic biomarkers are developed for neurological, metabolic, and renal diseases.
|
|
| domain | founded_year | HQ Location |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed.
|
|
| domain | founded_year | HQ Location |
Genome sequencing platform is provided for clinical diagnostics.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cartana
Frequently Asked Questions about CARTANA
When was CARTANA founded?
CARTANA was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Where is CARTANA located?
CARTANA is headquartered in Solna, Sweden.
Who is the current CEO of CARTANA?
Malte Kuhnemund is the current CEO of CARTANA. They have also founded this company.
Is CARTANA a funded company?
CARTANA is a funded company, having raised a total of $329.93K across 3 funding rounds to date. The company's 1st funding round was a Seed of $329.93K, raised on Oct 09, 2018.
What does CARTANA do?
CARTANA provides gene expression mapping technology in brain tissue. The company offers their technology of gene expression mapping in brain tissue via In Situ Sequencing (ISS), the 4th generation of sequencing technologies. The company technology and reagents are meant for research and biomarker discovery, treatment validation, and as a diagnostic tool.
Who are the top competitors of CARTANA?
Who are CARTANA's investors?
CARTANA has 3 investors. Key investors include 10X Genomics, European Union, and Almi Invest.